1. Functional Interleukin-21 Polymorphism Is a Protective Factor of Diffuse Large B-Cell Lymphoma
   Hui Wang et al, 2014, DNA and Cell Biology CrossRef
2. Improved Treatment of Breast Cancer with Anti-HER2 Therapy Requires Interleukin-21 Signaling in CD8+ T Cells
   Deepak Mittal et al, 2016, Cancer Research CrossRef
3. IL-21R functions as an oncogenic factor and is regulated by the lncRNA MALAT1/miR-125a-3p axis in gastric cancer
   Lei Yan et al, 2018, International Journal of Oncology CrossRef
4. Oxymatrine exhibits anti-tumor activity in gastric cancer through inhibition of IL-21R-mediated JAK2/STAT3 pathway
   Yanxia Huang et al, 2018, International Journal of Immunopathology and Pharmacology CrossRef
5. Polymorphism in interleukin 21 gene is associated with decreased susceptibility to diffuse large B cell lymphoma
   Jie Li et al, 2014, Tumor Biology CrossRef
6. T follicular helper cell-mediated IL-21 production suppresses FOXP3 expression of T follicular regulatory-like cells in diffuse large B cell lymphoma patients
   Xiaomei Ma et al, 2020, Human Immunology CrossRef
7. Epstein–Barr virus (EBV) provides survival factors to EBV+ diffuse large B‐cell lymphoma (DLBCL) lines and modulates cytokine induced specific chemotaxis in EBV+ DLBCL
   Liang Wu et al, 2017, Immunology CrossRef
8. The PD-1/PD-L1 Checkpoint in Normal Germinal Centers and Diffuse Large B-Cell Lymphomas
   Marcos Garcia-Lacarte et al, 2021, Cancers CrossRef
9. CXCR5+CD8+ T cells present elevated capacity in mediating cytotoxicity toward autologous tumor cells through interleukin 10 in diffuse large B-cell lymphoma
   Jiahong Tang et al, 2017, International Immunopharmacology CrossRef
10. IL-21 Stimulates the expression and activation of cell cycle regulators and promotes cell proliferation in EBV-positive diffuse large B cell lymphoma
    Yuxuan Wang et al, 2020, Scientific Reports CrossRef